Ajmaline clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2008
How each study uses Ajmaline is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Ajmaline
- 3
Studies by the year they started
3 studies that test it; most in 2008 (1)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2015 | 1 |
| 2017 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 3
IRCCS Policlinico S. Donato (1) · Hospital Clinic of Barcelona (1) · St George's, University of London (1)
Studies
Open first, then newest update. How each study uses Ajmaline is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- The Response To Ajmaline Provocation in Healthy SubjectsStatus unknownPhase 2St George's, University of LondonNCT02933437Written as Ajmaline
- Epicardial Ablation in Brugada SyndromeCompletedNot applicableIRCCS Policlinico S. DonatoNCT02641431Written as Ajmaline
- Ajmaline Utilization in the Diagnosis and Treatment of Cardiac ArrhythmiasCompletedPhase 4Hospital Clinic of BarcelonaNCT00702117Written as ajmaline
Codes
What other systems call Ajmaline · ClinicalTrials.gg INT006915
- MeSH (NLM) D000404AjmalineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 1PON08459RAJMALINEConfirmed FDA, NLM, Wikidata
- RxNorm 423Confirmed FDA, Wikidata
- Wikidata Q104249842AjmalineConfirmed FDA, NLM, Wikidata
- Wikidata Q385858ajmalineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C83524AjmalineOne source FDA
- DrugBank DB01426One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000404 | Ajmaline | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 1PON08459R | AJMALINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 423 | — | Confirmed FDA, Wikidata |
| Wikidata | Q104249842 | Ajmaline | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q385858 | ajmaline | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C83524 | Ajmaline | One source FDA |
| DrugBank | DB01426 | — | One source Wikidata |
Also registered as ajmaline hydrochloride (UNII 140MW6WGAF).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.